Recordati Industria Chimica e Farmaceutica S.p.A. (VIE:REC)
Austria · Delayed Price · Currency is EUR 50.40
+0.76 (1.53%)
At close: Nov 10, 2025
VIE:REC Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 632.32M EUR in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 2.55B, up 12.58% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.
Revenue (ttm)
2.55B
Revenue Growth
+12.58%
P/S Ratio
4.26
Revenue / Employee
574.08K
Employees
4,583
Market Cap
10.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
| Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
| Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
| Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
| Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 31.89B |
| Strabag SE | 17.92B |
| Voestalpine AG | 15.50B |
| Vienna Insurance Group AG | 13.13B |
| Erste Group Bank AG | 10.96B |
| Raiffeisen Bank International AG | 8.90B |
| VERBUND AG | 8.30B |
| Andritz AG | 7.84B |